Ernexa Therapeutics, Inc. (ERNA)
0.3028
0.00 (0.00%)
USD |
NASDAQ |
Mar 05, 16:00
0.2968
-0.01
(-1.98%)
After-Hours: 17:11
Ernexa Therapeutics Free Cash Flow : -9.436M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix, Inc. | -216.89M |
| Quince Therapeutics, Inc. | -38.98M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
| Tango Therapeutics, Inc. | -146.76M |
| Aprea Therapeutics, Inc. | -13.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.272M |
| Cash from Investing (Quarterly) | -0.022M |
| Cash from Financing (Quarterly) | 0.026M |
| Free Cash Flow Per Share (Quarterly) | -0.1573 |
| Free Cash Flow to Equity (Quarterly) | -1.253M |
| Free Cash Flow to Firm (Quarterly) | -1.294M |
| Free Cash Flow Yield | -105.5% |